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First Study: Background 
The thesis collects research conducted during the doctoral period.  
The first research is a pathophysiological study on athlete's heart and particularly on right 
ventricular function, myocardial instrumental in the athlete's performance. The study involved the 
use of new echocardiographic technologies, Speckle Tracking Echocardiography and three-
dimensional echo. Were compared 43 healthy sedentary subjects and 40 top-level athletes, all 
subjects were studied with standard echocardiography and with new echocardiographic 
technologies. There were no significant differences between the 2 groups with regard to the Doppler 
parameters, while the athletes had volumes (end-diastolic and end-systolic) larger without 
significant differences in ejection fraction. Longitudinal strain of the right ventricle, both the global 
and lateral wall it appeared higher in athletes, and there was a close correlation between the lateral 
longitudinal strain and the diastolic volume after adjustment for heart rate. We concluded that the 
determinants of supernormal function of the right ventricle can be very well identified by a 
combined study of the right ventricle with Speckle Tracking and three-dimensional 
echocardiography. The preload of the right ventricle does its utmost influence on the lateral 
longitudinal fibers, this effect results in an increase in stroke volume of the right ventricle. This 
study, which is the text in full, was published in Echocardiography (2014 Sep; 31 (8): 996-1004). 
First Study: 
Prominent contribution of free wall to supernormal right ventricular function in the athlete’s 
heart: combined assessment by Speckle Tracking and three-dimensional echocardiography 
Abstract 
The aim was to assess determinants of right ventricular (RV) function in top-level athletes by 
Speckle Tracking (STE) and real-time 3D echocardiography (RT3DE). RV function of 43 sedentary 
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normals and 40 top-level rowers was compared by standard echo-Doppler, RT3DE and STE. 
RV diameters, tricuspid annular plane systolic excursion (TAPSE), tricuspid E/A ratio and pulsed 
Tissue Doppler of lateral tricuspid annulus were analyzed. RV volumes, ejection fraction (EF) and 
stroke volume (SV) were determined by RT3DE. STE-derived RV global longitudinal strain 
(GLS) (average of 6 segments), septal strain (average of 3 septal regions, SLS) and lateral strain 
(average of 3 lateral regions, LLS) were estimated by STE. The 2 groups were comparable for age, 
body mass index and blood pressure but heart rate (HR) was lower in rowers. RV diameters were 
larger and TAPSE, E/A ratio, and Tissue Doppler derived s' and e' velocities higher in rowers. 
RT3DE RV end-diastolic volume (EDV) and end-systolic volume were greater in rowers (both 
p<0.0001), without EF difference. GLS (p<0.005) and LLS (p<0.001), but not SLS, were higher in 
rowers. In the pooled population LLS was related to EDV and SV, even after adjusting for HR 
(r=0.35, p<0.001 and r=0.33, p<0.002 respectively). Determinants of supernormal RV function of 
athletes can be identified by the combination of RT3DE and STE. RV preload exerts its maximal 
influence on the longitudinal lateral fibers, whose effect induces in its turn the increase of stroke 
volume.    
Key Words: Athlete’s heart, Right ventricle, Speckle Tracking Echocardiography, Longitudinal 
strain, Three-dimensional echocardiography  
Introduction  
Intensive endurance training in competitive athletes leads to cardiac morphological and functional 
changes that become gradually overt and disappear stopping the sport activity. The "athlete's heart" 
includes symmetrical and shapely increase in internal diameters and wall thickness of atrial and 
ventricular chambers [1-5]. Their final size could vary in dependence of type, intensity and duration 
of competitions and training sessions, individual physiological features (largely genetically defined) 
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and age at the time of training begin. While a large number of studies has been published on left 
ventricular (LV) features produced by intensive training, mainly LV hypertrophy [6-8], little is 
known about right ventricular (RV) morphology and function of the “athlete’s heart”. 
RV dysfunction is a recognized index of functional capacity as well as a survival predictor in 
several clinical conditions [9,10]. Nevertheless, the right ventricle has been long defined as the 
"forgotten” cardiac  chamber, an expression which points out its poor knowledge and is mainly 
related to its difficult ultrasound approach. This is due to its difficult location (just behind the 
breastbone, forward the left ventricle) [11] and its complex shape which includes three main 
portions: inflow tract (inlet), outflow tract (outlet), and a trabeculated muscular apex [12,13]. The 
localization of inflow and outflow tracts at two different levels makes RV internal volume to be 
unrelated to any geometric assumption. Recent development in ultrasound technology now allows a  
complete assessment of RV volumes and ejection fraction (EF) by real-time three-dimensional 
echocardiography (RT3DE) which enables this technique to compete with cardiac magnetic 
resonance imaging (MRI) [14,15], On the other hand, two-dimensional Speckle Tracking 
Echocardiography (STE) makes possible the assessment of RV regional and global longitudinal 
deformation [16,17]. Differently from the left ventricle, RV myocardial fibers arrangement is 
predominantly longitudinal and RV contraction is mainly due to longitudinal shortening [12]. In this 
view, STE-derived longitudinal strain can be very powerful diagnostic for RV functional 
assessment.   
The present study was designed to assess determinants of supernormal RV contractility in 
competitive athletes by combining the two novel technologies of RT3DE and STE.  
Methods 
Study Population 
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The study population included male italian top-level rowers (performing competitive activity for a 
period ranging from 4 to 12 years), consecutively visited in our Department under a written 
invitation forwarded to famous Nautical Associations of Naples and a control group of sedentary 
healthy normals recruited from the personnel of our university and their relatives involved in a 
screening prevention program. To be eligible, athletes had to be engaged in a mixed training 
program (isotonic and isometric) of at least 30 h per week in the last 4 years. They were examined 
during an intense training period, at least 24 h after last athletic activity. All participants gave 
written informed consent to the procedures before entering the study. They were judged to be free 
of cardiac disease on the basis of negative medical history, normal physical examination, 12-lead 
ECG, and Doppler echocardiographic examination. Blood pressure was < 140/90 mmHg in each 
subject. None had any disease or injury in the 4 weeks prior to the beginning of the study, nor were 
taking any medication, abusive substances (including anabolic steroids and GH), alcohol or 
smoking. After the exclusions, the study population included 40 athletes top-level rowers and 43 
healthy controls. 
Procedures 
The echocardiographic examinations were performed using a Vivid E9 ultrasound scanner (GE 
Healthcare, Milwaukee, Wi, USA). Heart rate and blood pressure (BP) (average of three 
measurements by a cuff sphygmomanometer) were measured at the end of the examination. Images 
acquisition and measurements determination of both conventional and advanced techniques 
(RT3DE and STE) were done according to standardized procedures [18-20].  
Standard echocardiographic examination. Standard echo examination was performed using a 2.5 
MHz transducer with harmonic capability according to the standards of our laboratory [18-20]. RV 
global systolic function was assessed as tricuspid annular systolic excursion (TAPSE, mm) by M-
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mode scanning of the lateral tricuspid annulus. In apical 4-chamber view pulsed Doppler RV inflow 
assessment was recorded to measure early diastolic (E) and atrial (A) peak velocities (m/sec) and 
E/A ratio at the tips of the tricuspid leaflets, and pulsed Tissue Doppler of the lateral tricuspid 
annulus to measure systolic (s’), early diastolic (e’) and atrial (a’) velocities (all in cm/sec) [21]. In 
the parasternal short-axis view of the great vessels pulsed Doppler of RV outflow tract was 
recorded and both pre-ejection period (RV PEP) and ejection time (RV ET) (both in msec) 
measured as parameters of RV systolic function.  
RT3DE. RT3DE data set acquisition of the left ventricle obtained using a 3D volumetric 
transducer. A full-volume RV scan was acquired from the apical approach using harmonic imaging, 
with adjustment of image contrast, frequency, depth and sector size for adequate frame-rate and 
optimal RV border visualization. Tricuspid valve, but not entire right atrium, was included in the 
data set throughout the cardiac cycle. Gain was set higher than for usual 2-D images [21]. 
Respiratory maneuvers were applied for optimizing endocardial border visualization, especially 
when RV anterior wall could not be otherwise encompassed in the data set. Then, consecutive 4-
beat ECG-gated sub-volumes were acquired during breath holding to generate the full-volume data 
set. Operators were requested to perform quality check by 2D RV multiplane display and 3D RV 
transversal plane during acquisition (Figure 1) as well as by 9-slice display immediately after 
acquisition (Figure 1). Adequate 3D data sets of the right ventricle were stored digitally in raw-data 
format. The software which provides 3D mesurements of RV function (4D-RV function, version 
2.6, TomTec Imaging Systems, Gmbh, Unterschleissheim, Germany) is clinically validated against 
cardiac MRI [14,15]. Every RV full-volume 3-D data set is automatically cropped in 3 standard 
planes (views): 4-chamber, coronal and sagittal. After optimizing each view according to 
anatomical landmarks (RV inflow and outflow), 3-D data sets can be manipulated by the reader 
with a series of translational, rotational and pivoting manoeuvres, for the reference line to pass 
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through the center of tricuspid valve and RV apex in each view. End-diastolic (largest RV area) and 
end-systolic (smallest area) frames are then manually set in 4-chamber view. Point identification for 
mitral and.tricuspid valve and LV apex are required. In the  assessment of the present study readers 
were required to trace endocardial border at end-diastole and end-systole for the 3 selected RV 
planes. Care was taken to trace endocardial border just outside the blood-tissue interface and 
papillary muscles, moderator band and endocardial trabeculae were included in RV cavity. These 
manually traced contours served for initiation of automated border detection algorithm. Frame-by-
frame orrection of endocardial border was applied when needed. Measurements of RV end-diastolic 
volume (EDV), end-systolic voume (ESV) and ejection fraction (EF) and stroke volume (SV) and 
cardiac output were finally obtained (Figure 2). Additional measurements of RT3DE included LV 
mass and LV mass index (g/m 
2.7
) which were obtained according to the standards of our laboratory 
[20]. 
Speckle Tracking Echocardiography. STE of the right ventricle was performed by recording an 
apical 4-chamber view according to a previously validated method, whose reproducibility has been 
previously reported [17]. Reliable recording of 2D images for STE requires a high frame rate (40-70 
frames/s), without dual focusing. To achieve this goal it is necessary to record RV cavity with the 
narrowest scan and at the lowest possible depth in order to display on the screen the left ventricle as 
large as possible. Care was also taken to obtain the best visualization of the right ventricle, such to 
obtain the best delineation of endocardial borders. Custom acoustic-tracking software was applied 
on 2D gray-scale images by tracking movements of “speckles” in the myocardial tissue, frame by 
frame throughout the cardiac cycle. The software is interactive (endocardial-cavity interface traced 
manually and epicardial tracing generated automatically) and rejects poorly tracked segments, 
allowing the observer to manual override its decision by visual assessment. The reading analysis 
was performed using a commercially available semi-automated 2D strain software in a dedicated 
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workstation (Echopac, GE). After the segmental tracking quality analysis and the eventual manual 
adjustement of the endocardial borders, the longitudinal strain curves were automatically generated 
for 6 RV regions of interest, 3 of free lateral wall and 3 of interventricular septum (Figure 3). Peak 
negative longitudinal strain was measured from the 6 segments. RV GLS was calculated by 
averaging values of the 6 segments. Segments with suboptimal tracking were exluded by the 
average. In addition, lateral longitudinal strain (LLS) was calculated as the average of the 3 regions 
of interest of the lateral wall and septal longitudinal strain (SLS) as the average of the 3 septal 
regions of interest.   
Statistical Analysis 
Statistical analysis was performed by SPSS package, release 12 (SPSS, Inc., Chicago, IL, USA). 
Data are presented as mean value + standard deviation (SD). Descriptive statistics was obtained by 
one-factor ANOVA and χ2 distribution with computation of exact p-value by the Monte Carlo 
method. Least squares linear regression was used to evaluate univariate correlates of a given 
variable. The null hypothesis was rejected at p ≤ 0.05. 
 Results            
            The characteristics of study population are listed in Table 1. The 2 groups were comparable 
for sex prevalence, age, body mass index and BP whereas heart rate was significantly lower in 
athletes than in controls (p <0.0001). 
Standard Doppler echocardiographic analysis of the right ventricle is summarized in Table 2.  
RV diameters were significantly larger (p<0.001), and TAPSE (p<0.001), tricuspid inflow E/A ratio 
(p<0.005) as well as pulsed Tissue Doppler derived s' and e' velocities (both p<0.002) higher in 
rowers while RV E/e' ratio did not differ between the 2 groups.  
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RT3DE analysis (Table 3) showed geater RV EDV and ESV in rowers (both p<0.0001), 
without significant difference in EF between the 2 groups .  
Table 4 reports STE results. Longitudinal strain of each of the 6 RV regional segments was 
significantly higher in athletes than in controls (p<0.005). LLS was significantly higher in rowers 
(p<0.0001) while SLS did not differ in comparison with the control group. 
Table 5 shows univariate correlations of STE parameters in the pooled population. RV LLS, but not 
GLS nor SLS, was significantly related with both RV EDV and SV (Table 6 (Figure 4.). These 
relations remained significant even after adjusting for heart rate (r = 0.35, p<0.001 and r = 0.33, 
p<0.002 respectively). 
Discussion 
The present study demonstrates the additional value of new ultrasound tecnologies in defining the 
features of the athlete’s heart. In absence of significant difference in RT3DE-derived EF in 
comparison with the control group, GLS and LLS were significantly higher in rowers. LLS was 
independently associated with EDV, a reliable marker of RV pre-load, and with SV. i.e. a true 
indicator of RV pump function.  
Previous studies used pulsed Tissue Doppler to assess RV myocardial function in the supernormal 
athlete’s heart [7,8,16,22]. These studies showed an increase of both RV systolic and early diastolic 
velocities as well as a prolongation of myocardial relaxation time, the latter two parameters being 
an expression of improved myocardial relaxation.  
New ultrasound technologies, such as RT3DE and STE, have already demonstrated to allow more 
accurate and reliable assessment of RV morphology and function in different clinical scenarios 
[15,16,23-28]. The peculiarity of the present study was the choice of a combined evaluation of the 
right ventricle by using STE, which allows accurate assessment of global and regional RV 
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myocardial longitudinal function, and RT3DE, which makes possible a feasible and reliable 
determination of RV volumes and EF [14,15]. Normal values of RV size and function by 3RTDE 
have been also determined in the clinical setting [29]. 
STE of the right ventricle has been already applied to the athlete’s heart. Recently D’Andrea et al. 
[27] demonstrated that, without difference of TAPSE obtained by M-mode assessment, RV GLS is 
substantially increased in endurance athletes in comparison with the sedentary controls. These 
results point out a training-induced improvement of RV longitudinal deformation which is 
detectable by STE but not by standard echocardiographic assessment. These authors also showed 
that LV end-diastolic diameter is an independent determinant of RV GLS, a finding which 
highlights an optimal cooperation between the two ventricles in athletes.  
The present study extends the knowledge of RV physiology of the super-trained heart. We 
confirmed the increase of RV GLS in the athlete’s heart since it was higher in rowers than in 
controls. Supernormal RV function appears therefore to be mainly sustained by the systolic 
deformation of longitudinal fibers. This is consistent with the assumption that RV systolic function 
involves mainly the contraction of longitudinal fibers which shortens the long axis and draws the 
tricuspid annulus towards the apex [12]. Of interest, the increased RV strain of our athletes was 
found to be associated to increase of RV (both end-diastolic and end-systolic) but in absence of 
changes in RV EF, this finding being in agreement with the concept that modifications of 
longitudinal deformation occur early than those involving chamber function. A mismatch between 
RV chamber function (normal) and longitudinal function (reduced as measured by TAPSE) was 
observed also in pathologic conditions such as in patients with mitral valve prolapse who had 
undergone cardiac surgery [30].  
To the best of our knowledge, the present study is the first to observe that the increased RV strain of 
athletes is predominantly due to the contribution of RV lateral wall. In fact, lateral strain, but not 
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septal strain, was significantly increased in our rowers. The prominent contribution of RV lateral 
wall to the supernormal contractility could be expected since interventricular septum is also 
involved in LV function. Under normal loading and electrical conditions the septum is concave 
toward the left ventricle in both systole and diastole, more prone therefore to LV mechanics 
participation [12]. Conversely, RV lateral wall is free to exert all its action on RV systolic function. 
Of interest, the main contribution of RV lateral strain to RV mechanics was recently found in 
patients after heart transplantation [17]. 
It is also worthy of note that LLS was significantly related to both RT3DE-derived RV EDV and 
RV SV, markers of RV preload and LV pump function respectively. This results is a practical 
demonstration of the Frank-Starling mechanism applied to RV chamber: the greater RV EDV the 
better contractility of RV longitudinal fibers of the lateral wall induced by the optimal stretching of 
myocardial fibers, the better RV systolic performance. Similar findings were previously observed 
by the use of simple pulsed Tissue Doppler in competitive swimmers who showed positive 
associations of increased e’ velocity of lateral tricuspid annulus with both greater RV end-diastolic 
diameter (preload) and increased SV (pump function) [7].     
Study limitations. Since a definite STE software for RV 2D-strain has not yet been created, we 
applied STE technique of the left ventricle to analyze RV regional and global strain. This can be 
considered as a limitation [31] although both feasibility and reproducibility of RV strain patterns 
and measurements are well recognized in the clinical setting [17].  
In conclusion, the combination of RT3DE and STE allows to increase the knowledge of 
determinants of RV function in rowers. Our findings demonstrate that, in absence of EF changes, 
RV global longitudinal function is increased, this increaset being mainly due to the contribution of 
lateral wall contraction. RV preload increase (EDV) may be responsible of RV supernormal 
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contractility in rowers since it could induce the increased RV strain deformation of the lateral wall 
which is in turn leads to a beneficial effect of global systolic performance (SV).  
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Figures 
Figure 1. RT3DE study of the right ventricle. 2D RV multiplane display and 3D RV transversal 
plane during acquisition (upper panel) as well as 9-slice display after acquisition were used for 
quality check (lower panel). 
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Figure 2. Final determination of RV end-diastolic volume (EDV), end-systolic voume (ESV), 
ejection fraction (EF) and stroke volume (SV) by RT3DE. 
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Figure 3. Assessement of RV regional longitudinal function (6 segments, 3 of RV lateral wall and 3 
of interventricular septum) by STE. In left upper panel, color representation of each myocardial 
segment longitudinal strain is superimposed on 2D imaging; in left lower panel, qualitative color 
M-mode strain representation referring to the 6 consecutive myocardial segments is showed; in 
right panel, changes in longitudinal strain of each myocardial segment during cardiac cycle is 
represented by colored curves with dotted white line corresponding to average strain. 
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Figure 4. Scatterplot and regression line between RV end-diastolic volume (EDV) (x-line) and RV 
lateral longitudinal strain (y line) in healthy sedentary controls (green dots) and rowers (blue dots). 
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Figure 5. Scatterplot and regression line between RV lateral longitudinal strain (x-line) and RV 
stroke volume (y-line) in healthy sedentary controls and athletes.   
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Tables 
Table 1: Characteristics of the study population 
 
 Controls  
(n = 43)  
Athletes  
(n = 40)  
 p  
Age (years)  29.0±5.8  28.3±9.5 ns  
BMI (Kg/m²) 23.2±3.0  24.2±2.5  ns  
Systolic BP (mmHg)  118.5±11.6  122.4±8.3  ns  
Diastolic BP (mmHg) 70.8±8.5   70.9±8.0  ns  
 Mean BP (mmHg)  86.7±8.1  88.1±7.3  ns  
Heart Rate (bpm)  68.4±10.6   55.3±8.0  <0.0001  
 
BMI = Body Mass Index, BP = Blood Pressure 
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Table 2:  Right Ventricular standard Echo Doppler parameters. 
 Controls  
(n = 43)  
Athletes  
(n= 40)  
p  
RV basal diameter (mm) 27.3±4.9  33.9±5.2  <0.001  
RV mid-cavity diameter (mm) 31.4±4.4  38.4±5.2  <0.001  
RV longitudinal diameter (mm) 68.0±8.1  75.3±9.4  <0.001  
TAPSE (mm) 23.0±3.2  25.6±2.4  <0.001  
Tricuspid inflow E/A ratio  1.7±0.4  1.9±0.4  <0.005  
Tricuspid annular s’ (cm/sec) 0.10±0.02  0.10±0.02  <0.002  
Tricuspid annular e’ (cm/sec) 0.10±0.02  0.20±0.03  <0.002  
Tricuspid annular a’ (cm/sec) 0.10±0.04  0.10±0.03  ns  
RV  E/e’ ratio  4.0±0.8  3.8±0.9  ns  
 
RV = Right Ventricle, TAPSE = Tricuspid annular peak systolic excursion  
 
 
 
 
 
 
26 
 
 
 
Table 3:  RT3DE derived RV parameters. 
 Controls  
(n = 43)  
Athletes  
(n = 40)  
 p  
RV EDV (ml) 127±44  189±44 <0.0001  
RV ESV (ml) 61±23  89±24  <0.0001 
RV SV(ml) 65±28  100±24  <0.0001 
RV EF (%) 52±6   53±6  ns  
 
EF = Ejection Fraction, EDV =End Diastolic Volume, ESV = End Systolic Volume, RV = Right Ventricle 
 
Table 4:  STE RV longitudinal strain parameters. 
 Controls  
(n = 43)  
Athletes  
(n = 40)  
 p  
RV GLS (%) -24±2  -26±3 <0.005 
RV LLS (%) -26±4  -29±4  <0.0001 
RV SLS (%) -23±4  -24±4  Ns 
 
GLS = Global Longitudinal Strain, LLS = Lateral longitudinal strain, SLS = Septal longitudinal strain,  RV = Right 
Ventricular 
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Table 5: Univariate correlations of STE parameters in pooled population. 
Dependent variable  TAPSE s’ SV(3D) 
GLS   r=0.11 r=0,20 r=0.20 
 Ns ns Ns 
LLS   r=0.19 r=0.15 r=0.99 
 Ns ns p<0.0001 
SLS   r=0.06 r=0.12 r=0.06 
 Ns ns Ns 
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Second Study: Background  
Using new echocardiographic technologies, especially Speckle Tracking Echocardiography, we 
developed the second study accepted for publication on Hypertension. We evaluated impact of 
pulse pressure on left ventricular systolic function. We enrolled 143 patients (68 newly hypertensive 
patients, never treated, and 75 normotensive subjects), all patients underwent complete 
echocardiographic study, with Doppler and Spckle Tracking. Study population was divided in two 
groups according pulse pressure tertiles. Group 1 included the first and the second tertile (n = 93 
with pulse pressure < 55mmHg), group 2 included the third tertile (n = 50 with pulse pressure > 
55mmHg). Left ventricular mass was significantly higher in the third pulse pressure tertile, while 
relative wall thickness did not significantly differ. Global longitudinal strain and E/A ratio were 
lower in the third tertile, while E/e’ ratio resulted higher.  Moreover multiple linear regression 
analysis showed that pulse pressure and overweight were independently correlated to global 
longitudinal strain. Thus, elevated pulse pressure negatively impacts on left ventricular longitudinal 
function. 
Second Study: 
Impact of pulse pressure on left ventricular global longitudinal strain in normotensive and 
newly diagnosed, untreated hypertensive patients 
Abstract 
Objectives: Little is known about the impact of pulse pressure (PP) on left ventricular (LV) 
systolic function. Aim of our study was to evaluate whether high PP is associated with subclinical 
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LV systolic dysfunction. 
Methods: The study population included 143 participants (68 newly-diagnosed, never-treated 
hypertensive and 75 normotensive subjects) evaluated by echo-Doppler, including determination 
of global longitudinal strain (GLS) by Speckle Tracking. According to PP tertiles, participants 
were divided in 2 groups: the first group merging the 1st and 2nd PP tertiles (n=93, PP ≤ 55 
mmHg) and the second group including the highest PP tertile (HPPT) (n=50, PP > 55 mmHg). 
Results: The two groups were comparable for sex, body mass index and heart rate whereas age 
was higher in subjects with the HPT (p<0.0001). LV mass index was significantly higher in 
subjects with the HPPT (p<0.01), with no significant difference in relative wall thickness. Among 
several indices of LV systolic function, only GLS was lower in subjects with the HPPT (p<0.001). 
Transmitral E/A ratio (p=0.006) was lower and E/e’ ratio higher (p<0.001) in the HPPT group. By 
a multilinear regression analysis, HPPT (p<0.020) and overweight (p=0.025) were independent 
correlates of low GLS. Replacing HPPT with the highest systolic blood pressure (SBP) tertile, 
GLS was independently associated with body mass index (p=0.040) but not with the highest SBP 
tertile (p=0.069) .Conclusion: Elevated PP negatively influences LV longitudinal mechanics in a 
mixed population of normotensive and untreated hypertensive subjects. 
Introduction 
Recent ESC/ESH guidelines for management of arterial hypertension consider the absolute values 
of systolic and/or diastolic blood pressure (BP) to classify hypertensive stages and cardiovascular 
(CV) risk [1]. However, another important feature taken into account is pulse pressure (PP), which 
is calculated as the difference between systolic and diastolic BP. PP exhibits a wide range of 
values, depending on increased systolic BP, decreased diastolic BP or both [2]. PP is a raw 
estimate of arterial stiffness [3-6] and is directly related to CV alterations found in hypertensive 
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patients [7-10]. Although CV remodeling and dysfunction are mainly due to the mechanical stress 
resulting from elevated systolic and/or diastolic BP [11-12], PP is critically important as the 
pressure amplification of LV stroke at the level of conduit arteries [12,13]. PP has been 
demonstrated to increase CV risk in middle-aged [2,14] and elderly subjects [15]. It was also 
independently associated with subclinical CV disease in the 6776 participants of the Multiethnic 
Study of Atherosclerosis, which included both normotensive and hypertensive patients [16]. In this 
view, it is conceivable that PP could be considered a marker of pre-clinical CV disease rather than 
a true CV risk factor [17]. 
Speckle Tracking Echocardiography (STE), a simple and feasible ultrasound technique which can 
be easily performed during a standard echocardiographic exam, provides a quantitative analysis of 
LV deformation in the three orthogonal planes (longitudinal, circumferential and radial) and LV 
twisting [18-20]. Among the different LV deformation components, global longitudinal strain 
(GLS) has been identified to be an earlier marker of subclinical cardiac damage than LV ejection 
fraction [18-20]. Worthy of note, reduced GLS has also been found to be associated with a two-
element windkessel model estimate of arterial stiffness (PP/stroke volume ratio) in a middle age 
series, which included 70 hypertensive patients and 30 normotensive volunteers [21]. 
The present study was designed to evaluate the relation between PP and LV systolic 
function in a population of normotensive and untreated hypertensive subjects, by assessing 
several echocardiographic systolic indices - including GLS – in relation with the other BP 
components, LV geometry and parameters of diastolic function. 
Methods 
Study population 
 
After their informed consent was obtained, 68 consecutive, newly-diagnosed, never-treated 
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hypertensive outpatients and 75 normotensive subjects, recruited among the staff of the Federico II 
University hospital on a voluntary basis for a screening on early diagnosis of hypertension, 
underwent a standard transthoracic echo-Doppler study, including STE of the three apical views. 
Criteria of exclusion were age < 30 years, diabetes mellitus, coronary artery disease, overt heart 
failure, valve heart disease (any stenosis and more than trivial mitral or aortic regurgitation), 
primary cardiomyopathies, atrial fibrillation or inadequate echocardiographic imaging. The 
diagnosis of arterial hypertension was established for BP values ≥ 140 mmHg systolic and/or 90 
diastolic BP as the average of three measurements in the sitting position in three different visits. 
BP was also measured in supine position by a cuff sphygmomanometer at the end of 
echocardiographic exam (average of three measurements) and this measurement was chosen for 
statistical analysis in order to obtain an almost simultaneous evaluation of echocardiographic 
parameters and LV afterload. 
Echo Doppler examination 
 
Standard echo Doppler and STE were performed by a Vivid E9 ultrasound machine (GE 
Healthcare, Horten, Norway), using a 2.5 MHz transducer with harmonic capability. 
Two-dimensional and Doppler exam were performed according to the standards of our laboratory 
[22,23]. The quantitative analysis of the left ventricle was done in agreement of 2015 ASE/EACVI 
recommendations [24]. Two-dimensional echocardiographic LV ejection fraction was computed 
from LV end-diastolic and end-systolic volumes (from apical 4- and 2-chamber views) measured 
by the modified Simpson rule. LV mass was calculated by 2D guided M-mode imaging or directly 
from 2D longitudinal long-axis view and indexed for height powered to 2.7 [25]. LV hypertrophy 
was defined as LV mass index > 47 g/m2.7 in women and > 50 g/m2.7 in men [26]. 
Relative diastolic wall thickness was computed as the sum of anterior septal wall thickness and 
posterior wall thickness divided by LV diastolic diameter. Midwall fractional shortening was 
 32 
 
calculated according to a validated formula as an index of LV midwall mechanics [27]. Left 
atrial volume (area-length method in apical 4- and 2-chamber vies) was indexed for body surface 
area [24]. Transmitral Doppler inflow and pulsed Tissue Doppler were recorded in apical 4-
chamber view. The average of the peak early systolic (s’) and diastolic velocity (e’) of the septal 
and lateral mitral annulus velocities were calculated and the ratio of transmitral peak early 
velocity (E) to average e’ (E/e’ ratio) derived as an estimate of LV filling pressure [22,23,28]. 
All Doppler measurements were averaged from 3 cardiac cycles. 
STE procedures were performed according to the standard of our laboratory [23]. STE of the left 
ventricle was recorded on 2-D images of three consecutive cardiac cycles from the three apical 
views (long axis, 4- and 2-chamber) at an approximately equal heart rate. LV cavity was 
recorded with the narrowest scan and at the lowest possible depth in order to obtain the left 
ventricle as large as possible on the screen and a frame rate of 40-70 frames/s. The same field 
depth was maintained for all the views. An interactive software (endocardial-cavity interface 
traced manually and epicardial tracing generated automatically) rejects segments of poor imaging 
quality, allowing the observer to manual override its decision by visual assessment. The time of 
aortic valve closure (AVC) was marked in the apical long-axis view, as the driving view, and used 
as reference point in all the other views. Each of the three apical images was automatically divided 
into 6 myocardial segments. Peak negative longitudinal strain was measured from 6 segments in 
each of the 3 apical views (long-axis, 4- and 2-chamber) and global longitudinal strain (GLS) 
calculated as the average of individual percent peak strain before AVC. Reproducibility of STE in 
our laboratory has been previously reported [29]. 
Statistical analysis 
 
Statistical analysis was performed by SPSS package, release 12 (SPSS Inc, Chicago, Illinois, 
USA). Data are presented as mean value ± SD. Participants were divided into tertiles of PP, and 
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the highest tertile was compared to the merged lowest and middle tertiles. The cut point of the 
highest tertile (i.e. the 67th percentile of the distribution) was ≥ 55 mmHg. Descriptive statistics 
was obtained by one-factor ANOVA/ANCOVA and χ2 distribution with computation of exact p 
value by Monte Carlo method. Least squares linear regression was used to evaluate univariate 
correlates of a given variable. Multiple linear regression analyses were performed to study 
independent correlates of GLS, also considering potential multicollinearity by computation of 
variance inflation factor. Collinearity was considered acceptable and regression model stable for 
variance inflation factor <3. The null hypothesis was rejected at 2-tailed p<0.05. 
Results 
The HPPT included 50 subjects while the other group (1st  and 2ndtertile) comprised together 93 
subjects. In the HPPT, 33 (66.0%) were hypertensive and 17 (34%) were normotensive. 
The clinical characteristics of the two study groups are listed in Table 1. The two groups were 
comparable for sex-distribution, body mass index, heart rate and diastolic BP. Systolic BP, mean 
BP (both p<0.0001) and age (p<0.0001) were higher in the HPPT. 
Table 2 shows that LV mass index (p<0.01) was higher in the HPPT than in the other group, 
without significant differences in relative wall thickness. Among the different indices of LV 
systolic function, only GLS was significantly lower in the HPPT (p<0.001). By restricting the 
analysis to the hypertensive group, GLS was confirmed lower in the HPPT (-19.2±1.9 vs. -
20.4±2.2%, p<0.02). 
Among LV diastolic parameters, transmitral E/A ratio (p=0.006) and e’ velocity (p<0.0001) 
were lower in the HPPT, whereas a’ velocity (p<0.005) and E/e’ ratio (p<0.001) were higher. 
LV hypertrophy was detected in 8/143 (5.6%, all in the hypertensive group) of the study 
population, 6/50 patients in the HPPT (12.0%) and 2/75 in the other group (2.7%) (p<0.01). 
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Univariate correlations 
 
Table 3a shows the univariate relations of GLS and PP in the pooled population. GLS was 
negatively correlated to body mass index, systolic BP, diastolic BP, mean BP and PP (Figure 1). 
PP was positively related to age, LV mass index and E/e’ ratio and negatively to average e’ 
(Table 3b). Even after adjusting for age, sex and mean BP (ANCOVA), the correlation between 
GLS and PP remained significant (p=0.003; data not in table). 
Multiple linear regression analyses 
 
By a multiple linear regression analysis - including age, body mass index, HPPT, LV mass index 
and E/e’ ratio as potential independent correlates of GLS in the whole population - HPPT 
(p<0.020) and overweight (p<0.025) were independently associated with the lowest GLS, with 
PP exhibiting the highest standardized β-coefficient (Table 4, Model 1). Replacing HPPT with 
the highest systolic BP tertile (≥140 mmHg), GLS was independently associated with body mass 
index (p=0.040) but not with the highest systolic BP tertile (p=0.069) (Table 4, Model 2). In a 
subsequent multiple linear regression analysis we considered age, body mass index, LV mass 
index and E/e’ ratio and both the physiological components of BP, mean BP (as the steady 
component) and PP (as the pulsatile component). By this analysis, GLS was independently 
associated with PP (standardized β coefficient = -0.204, p=0.031) and body mass index (β = -
0.181, p=0.040,) but not with mean BP (β = -0.133, p=0.191) (cumulative R2= 0.11, SEE = 2.4 
%, p<0.01) (data not shown in Table 4). 
Discussion 
Our findings demonstrate that in a population which included both normotensive and hypertensive 
subjects (1) GLS is significantly lower in the HPPT corresponding to abnormally increased PP (≥ 
55 mmHg) and (2) GLS and elevated PP are associated independently of clinical and 
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echocardiographic confounders. In this context, high PP - corresponding to the 67th percentile of 
the distribution - has the strongest impact on GLS. 
Arterial stiffness is a predictor of cardiovascular morbidity and mortality [30]. Increased PP is 
generally accepted as a raw index of arterial stiffness and a marker of arteriosclerosis, as it reflects 
the difficulty in distending conduit arteries and the loss of arterial elasticity [3-6]. Thus, PP could 
be considered as an independent marker of established pre-clinical CV disease more than a true 
CV risk factor [17]. 
In the present study we chose the third PP tertile (HPPT = PP ≥ 55 mmHg) as representative of 
abnormally increased PP. It is of interest that a definite cut-off point of 55 mmHg for normal PP, 
was reported also as the highest percentile of the distribution in the normal population of the 
Reference Values for Arterial Measurements Collaboration Group [31]. The choice of this cut-
off point, lower than that reported in other studies [16,17], can be further justified by the fact that 
our population comprised normotensive and newly diagnosed hypertensive subjects, with a low 
prevalence of LV hypertrophy (= 5.6% ), a finding which can be explained with the likely short 
duration of elevated BP history. Nevertheless, GLS was significantly reduced in subjects with 
high PP and this difference remained significant even when tested in the only hypertensive 
patients. 
Previous studies investigated possible association of both arterial stiffness and PP with LV 
diastolic dysfunction in hypertensive patients [32,33]. In particular, Mottram et al observed an 
independent association between PP and the degree of E/e’ ratio, taken as a non-invasive 
estimate of LV filing pressure [32]. Our study is the first to extend the association of PP with a 
parameter of LV systolic function. We explored not only GLS but also other indices of LV 
systolic function: an index of LV chamber function such as ejection fraction, an estimate of wall 
mechanics such as midwall fractional shortening, prognostically validated in arterial 
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hypertension [26], and a good surrogate of LV longitudinal function of LV base as s’ velocity of 
mitral annulus is [18]. Among these LV systolic indices, only GLS was able to differentiate 
subjects with normal and elevated  PP. 
GLS refers to LV longitudinal function and is thought to be due to the shortening of 
cardiomyocytes that are longitudinally oriented in subendocardium [18-20]. It has been shown to 
be a much more precocious index of LV longitudinal dysfunction than s’ velocity [18]. GLS has 
been studied in several cardiac conditions, and it was always able to detect early subclinical 
dysfunction [18-20]. GLS has been also demonstrated to be a prognosticator in the clinical setting 
[34]. 
Univariate relations provided additional information in the present study as they highlighted an 
inverse association between PP and GLS considered as continuous variables (both in 
the pooled population and in hypertensive group). The choice of potential confounders in the 
multivariate analyses involved age, body mass index, diastolic BP, LV mass, E/e’ ratio because of 
their relationships with GLS and or PP [18-20,35,36]. After adjusting for these confounders, the 
HPPT, i.e. an abnormally elevated PP, and GLS remained independently associated in the pooled 
population. Conversely, if we considered the highest systolic BP tertile, it did not enter the model 
in alternative analysis. We could not test simultaneously PP and systolic BP because of their high 
level of collinearity. Thus, we may speculate that the association of elevated PP with GLS 
reduction is not simply due to the elevated systolic BP. Systolic BP, representing the peak of BP 
change, is essential for PP trait but it is not the only determinant. To better understand 
pathophysiology of GLS, we also compared the independent associations of two hemodynamic 
components of pressure and flow: mean BP, which represents the steady component and the same 
PP, i.e. the pulsatile component [37]. Both factors contribute to the mechanisms underlying arterial 
hypertension but, in the present study, only PP was related to the very precocious LV systolic 
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impairment expressed by a lower GLS. 
To the best of our knowledge, our study is the first one demonstrating a correlation between PP 
and early LV systolic dysfunction in a population including both hypertensive patients and healthy 
normotensive. The increase of BP is a gradual process and the CARDIA study [38] has very 
recently shown that, over the years, cumulative BP (millimeters of mercury x year) exerts a 
negative impact on GLS (but not on ejection fraction). In the CARDIA study, though few subjects 
exceeded thresholds for BP treatment, LV dysfunction associated with cumulative BP was 
unrelated to a specific BP threshold, which reflects the uncertainty in establishing a definite cut-off 
value for deciding BP treatment. 
Increased PP is clearly associated with cardiovascular remodeling, involving both vessels and 
heart. Development of sclerosis in arteries is responsible of the arterial stiffness while an early 
development of myocardial fibrosis is responsible of the negative influence on LV longitudinal 
function. Myocardial fibrosis has been shown to be associated with increased arterial stiffness [39] 
and LV longitudinal dysfunction [40]. We recently demonstrated that in uncomplicated 
hypertensive patients the presence of myocardial fibrosis detected by late gadolinium enhancement 
applied to cardiac magnetic resonance is independently associated with a lower GLS [41]. 
Longitudinal strain and torsion have been found also to correlate significantly with serum levels of 
tissue inhibitor of matrix metalloproteases, a marker of myocardial interstitial fibrosis, in 
hypertensive patients [42]. Our data also confirm previous studies reporting a reduction of GLS in 
young hypertensives [29] and in borderline pre-hypertensive subjects [43], two categories of 
subjects in which the cardiac damage is believed to be minimal or even absent. 
In conclusion, our study confirms the role of PP as a pre-clinical marker of target organ damage 
extending its negative impact on LV longitudinal function, when other indices of LV systolic 
function are still normal, in a population of both normotensive and hypertensive subjects. This 
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association is independent of major confounders, such as overweight, LV hypertrophy, and LV 
diastolic dysfunction. Subjects with abnormally clinical high PP could be therefore identified as a 
group at risk for development of subsequent heart failure. In this clinical setting assessment of LV 
longitudinal function might be worth to identify very early myocardial dysfunction. 
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Figures 
Figure 1. Scatterplot and regression line of individual values of pulse pressure (x-line) 
and corresponding values of GLS (y line) in the pooled population. Values of GLS 
considered as “positive” (sign +) to build the association in order to homogenize the 
results of analyses and strengthen their clinical meaning: the higher values the better 
strain deformation independent on the plus/minus sign. 
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Tables 
Table 1. Clinical data of the study population 
 
 PP <55mmHg 
(n = 93) 
PP ≥ 55 mmHg 
(n = 55) 
P value 
Sex (F/M) 40/53        19/31 0.364 
Age (years)       45.0 ± 10.7 54.4 ± 11.7 0.0001 
BMI (kg/m2)     25.8 ± 3.9 26.6 ± 4.1 0.245 
Systolic BP (mmHg)     126.1 ± 12.5 150.8 ± 18.8 0.0001 
Diastolic BP (mmHg)      82.8 ± 12.4 86.1 ± 12.8 0.142 
Mean BP (mmHg)     97.3 ± 12.1 107.7 ± 14.3 0.0001 
Heart rate (bpm)     69.1 ± 13.0 73.7 ± 13.9 0.072 
 
BMI= Body mass index, BP= Blood pressure, PP= pulse pressure 
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Table 2. Echo-Doppler data of the study population 
 
 PP<55mmHg 
(n=93) 
PP≥55mmH
g (n=50) 
P value 
IVST (mm) 8.4 ± 1.3 8.8 ± 1.7 0.108 
PWT (mm) 8.1 ± 1.2 8.4 ± 1.4 0.176 
LVIDd (mm) 49.2 ± 4.7 49.4 ±5.1 0.785 
LVIDs (mm) 32.4 ± 4.4 31.8 ±6.3 0.572 
LVMi (g/m2.7) 33.1 ± 6.7 36.6 ±9.2 0.011 
RWTd 0.34 ± 0.05 0.35 ± 0.06 0.165 
LVEF (%) 62.7 ± 5.4 62.7 ± 5.9 0.984 
MFS (%) 18.0 ± 3.1 17.9 ± 3.1 0.994 
Average s’ (cm/sec) 9.5 ± 5.0 8.5 ± 1.8 0.159 
GLS (%) -20.9 ± 2.3 -19.5 ± 2.1 0.001 
LAV i (ml/m2) 23.4 ± 7.9 26.6 ± 7.9 0.050 
E/A ratio 1.21 ± 0.3 0.98 ± 0.3 0.006 
DT (ms) 182.5 ± 48.9 208.6 ± 46.5 0.050 
Average e’ (cm/sec) 11.4 ± 2.8 9.6 ± 2.7 0.0001 
Average a’ (cm/sec) 10.4 ± 2.0 11.2 ± 2.7 0.005 
E/e’ ratio 6.63 ± 1.73 7.75 ± 2.39 0.001 
 
 
DT= E velocity deceleration time, GLS= Global longitudinal strain, IVST = Interventricular septal wall 
thickness, LV = Left ventricular, LVIDd = LV internal diameter at end-diastole, LVIDs = LV internal 
diameter at end-systole, MFS = Midwall fractional shortening, PP= pulse pressure, PWT = Posterior wall 
thickness, RWTd = relative diastolic wall thickness, LAVi= left atrial volume index, LVEF= LV ejection 
fraction, LVMi= LV mass index. 
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Table 3. Correlations of LV GLS and PP in the pooled population. 
 
Dependent variable Correlate R P 
value 
*GLS (%) Age (years) -0.03 0.718 
BMI (kg/m2) -0.22 0.008 
Systolic BP (mmHg) -0.28 0.001 
Diastolic BP (mmHg) -0.18 0.027 
Mean BP (mmHg) -0.24 0.004 
PP (mmHg) -0.24 0.004 
LVMi (g/m2.7) -0.10 0.217 
RWTd -0.12 0.149 
E/A ratio 0.10 0.232 
Average e’ 0.18 0.026 
E/e’ ratio -0.12 0.141 
 
 
Dependent variable Correlate R Pvalue 
*PP Age (years) 0.32 0.001 
BMI (kg/m2) 0.07 0.418 
GLS (%) -0.24 0.004 
LVMi (g/m2.7) 0.25 0.002 
RWTd 0.14 0.102 
E/A ratio -0.27 0.001 
Average e’ -0.23 0.005 
E/e’ ratio 0.24 0.003 
Abbreviations as in Table 1 and 2 
 
*Values of GLS considered as “positive” (sign +) to build the associations in order to homogenize the results of analyses 
and strengthen their clinical meaning: the higher values the better strain deformation independent on the plus/minus 
sign.
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Table 4. Multiple linear regression analysis in the pooled population Model 1 
Dependent 
variable 
Correlate Standardized β 
coefficient 
p value Variance 
Inflation Factor 
*GLS (%) Age (years) -0.056 0.539 1.199 
BMI (kg/m2) -0.198 0.025 1.095 
Highest PP tertile (mmHg) -0.202 0.020 1.123 
LV mass index (g/m2.7) -0.030 0.969 1.100 
E/e’ ratio -0.057 0.535 1.271 
Cumulative R2 = 0.113 , SEE =2.3%, p<0.01 
 
 
Model 2 
 
Dependent 
variable 
Correlate Standardized β 
coefficient 
p value Variance 
Inflation Factor 
*GLS (%) Age (years) -0.017 0.845 1.130 
BMI (kg/m2) -0.182 0.040 1.109 
highest SBP tertile (mmHg) -0.159 0.069 1.086 
LV mass index (g/m2.7) -0.013 0.882 1.285 
E/e’ ratio -0.041 0.662 1.098 
Cumulative R2 = 0.101 , SEE =2.2 %, p<0.02 
 
Abbreviations as in Tables 1 and 2. 
 
*Values of GLS considered as “positive” (sign +) to build the associations in order to homogenize the results of 
analyses and strengthen their clinical meaning: the higher values the better strain deformation independent on the 
plus/minus sign. 
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Third Study: Background 
Third study enrolled population of the Campania Salute Network registry and it was published on 
Journal Human Hypertension, 2015 Sep 10. The study evaluated predictors of progression toward 
isolated systolic hypertension in patients with systo-diastolic hypertension. We studied 7801 
hypertensive patients without cardiovascular disease and/or chronic kidney failure, with at least 6-
months follow-up period. Prevalence of  isolated systolic hypertension was 21%. Patients with 
isolated systolic hypertension were older, with higher percentage of female sex, with loger history 
of hypertension and higher incidence of diabetes. Left ventricular mass, arterial stiffness, relative 
wall thickness, and intima-media thickness were also higher in patients with isolated systolic 
hypertension. Our findings suggest that isolated systolic hypertension is a manifestation of 
atherosclerotic disease worsening on target organ damages. It should be done more efforts to 
prevent the progression toward isolated systolic hypertension through more aggressive 
antihypertensive treatments, especially in subjects with fenotype at risk. 
Third Study: 
Identification of Phenotypes at Risk of Transition from Diastolic Hypertension to Isolated 
Systolic Hypertension 
 
Abstract 
 Little is known about the potential progression of hypertensive patients towards isolated systolic 
hypertension (ISH) and about the phenotypes associated with the development of this condition. 
Aim of this study was to detect predictors of evolution towards ISH in patients with initial systolic-
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diastolic hypertension. We selected 7,801 hypertensive patients free of prevalent cardiovascular 
diseases or severe chronic kidney disease, and with at least 6-month follow-up from the Campania 
Salute Network. During 55 ± 44 months of follow-up, incidence of ISH was 21%. Patients with ISH 
at the follow-up were significantly older  (p<0.0001) had longer duration of hypertension, higher 
prevalence of diabetes and were more likely to be women (all p<0.0001). They exhibited higher 
baseline left ventricular mass index, arterial stiffness (Pulse Pressure/Stroke index), relative wall 
thickness, and carotid intima-media thickness (all p<0.001). Independent predictors of incident ISH 
were older age (OR=1.14/5 years), female gender (OR=1.30), higher baseline systolic blood 
pressure (OR=1.03/5 mmHg), lower diastolic blood pressure (OR=0.89/5 mmHg), longer duration 
of hypertension (OR=1.08/5 months), higher left ventricular mass index (OR=1.02/5g×m
-2.7
), 
arterial stiffness (OR=2.01), relative wall thickness (OR=1.02), intima-media thickness 
(OR=1.19/mm; all p<0.0001), independently of antihypertensive treatment, obesity, diabetes and 
fasting glucose (p>0.05). Our findings suggest that ISH is a sign of aggravation of the 
atherosclerotic disease already evident by the target organ damage. Great efforts should be paid to 
prevent this evolution and prompt aggressive therapy for arterial hypertension should be issued 
before the onset of target organ damage, to reduce global CV risk.  
KEY WORDS : hypertension, blood pressure, ventricular mass, carotid intima-media thickness, 
aging.  
Background 
Systolic blood pressure (SBP) increases with ageing (1;2), in relation to environmental stimuli (3). 
The age-related increase in SBP is also associated with decline of diastolic BP (DBP), mainly due 
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to loss of elasticity and consequent stiffening of conduit arteries (1-4), often producing isolated 
systolic hypertension (ISH)(4).  
In the past, ISH has been considered almost as a physiologic condition, but in more recent 
decades, several studies have provided evidence that elevated SBP is an independent predictors of 
adverse cardiovascular (CV) outcomes, even more potent than elevated DBP, and that aggressive 
treatment of ISH might reduce hospitalization and mortality for CV causes (5-7). It has been 
calculated that for every 10 mmHg increase in SBP there is a 26% increase in overall mortality (7).  
Although some information is available on characteristics of subjects from a general 
population who develop ISH (8), little is known on the possible evolution towards ISH in treated 
hypertensive patients initially presenting with diastolic or systolic-diastolic hypertension. 
Accordingly, the present study was designed to assess whether and in which circumstances 
systolic-diastolic or isolated diastolic hypertension progresses into ISH. We focused on the 
identification of potential predictors of this progression in a large outpatient hypertensive 
population sample from our tertiary care center. 
Methods 
Patients 
The Campania Salute Network (CSN) is an open registry collecting information from a network of 
60 general practitioners and 23 community hospitals networked with the Hypertension Research 
Center of the Federico II University Hospital (Naples, Italy). The database generation of the CSN 
was approved by the Federico II University Hospital Ethic Committee. Signed informed consent 
was obtained from all the participants to use data for scientific purposes. Detailed characteristics of 
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this population have been previously reported (9-10). The database included over 12,000 patients, 
of whom 10,254 had confirmed arterial hypertension.  
For the present study, we selected 7,801 patients with systolic-diastolic or isolated diastolic 
hypertension and with at least 6-month follow-up. The presence of ISH at baseline was an exclusion 
criteria for our selection. Moreover, all patients were free of prevalent CV disease (defined as 
previous myocardial infarction, angina or procedures of coronary revascularization, and/or history 
of stroke) and without chronic kidney disease more than stage 3. In the CSN, both prevalent and 
incident CV disease were adjudicated by an internal Committee for Event Adjudication and was 
based on patient history, contact with the reference general practitioner, and clinical records 
documenting occurrence of disease.  
All hypertensive patients of the network underwent baseline echocardiograms and 
ultrasound evaluation of carotid arteries.  
Protocol and Definitions 
During baseline and follow-up visits, blood pressure, heart rate, body mass index (BMI), lipid and 
glucose profile were measured by standard methods.  Diabetes was defined according to the 
American Diabetes Association criteria (11). Obesity was defined by BMI≥30. (12) Glomerular 
filtration rate (GFR) was estimated using serum creatinine and simplified Modification of Diet in 
Renal Disease (MDRD) equation (13). According to GFR values, we excluded patients with higher 
than stage II chronic kidney disease (CKD), meaning a GFR < 59 mL/min/1.73 m
2
 in KDOQI 
classification (13). BP was measured at the clinical visit with a digital sphygmomanometer 
(OMRON M7). In patients with frequent arrhythmias or atrial fibrillation we adopted a aneroid  
sphygmomanometer (Erka Perfect) calibrated every 6 months. Following current guidelines, the 
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blood pressure was measured 3 times in the sitting position after 5 minutes rest, and the average of 
the 2 last measurements was taken as the office BP.  
 Diastolic hypertension was defined as diastolic BP90 mmHg in at least 2 consecutive visits 
combined or not with systolic BP140 mmHg (systolic-diastolic hypertension) . Diagnosis of 
follow-up ISH was made at the time of the last available outpatient visit, according to European 
Guidelines (systolic BP ≥140 mmHg with diastolic BP<90 mmHg). (14).   
Cardiac Ultrasounds 
Patients underwent M-mode and 2D-echocardiography, using a dedicated ultrasound machine 
(SONOS 5500; Philips, Andrews, Maryland, USA). Measurements were performed as previously 
reported (15;16), according to the American Societies of Echocardiography / European Association 
of Echocardiography (ASE/EAE) Recommendations (17) .  
 Left ventricular mass (LVM) was measured at end diastole and normalized for body height in 
meters to the power of 2.7 (LVMi).(18). Left ventricular hypertrophy (LVH) was defined as LVMi 
≥49.2 g/m2.7 in men and ≥ 46.7 g/m2.7 in women. (18).  Relative wall thickness (RWT) was 
calculated as posterior wall thickness/left ventricular end-diastolic radius (19). Pulse pressure (PP) 
to stroke index (SVi, by z-derived, normalized by height
2.04
) (20;21), was used as a crude estimate 
of arterial stiffness. 
Carotid Ultrasound 
Carotid ultrasound was carried out in the supine position with the neck extended in mild rotation. 
The scanning protocol was performed with an ultrasound device (SONOS 2500/5500, HP, Philips) 
equipped with a 7.5 MHz high-resolution transducer with an axial resolution of 0.1 mm. 
Examinations were recorded on S-VHS videotapes and then analyzed off-line. The maximal arterial 
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intima-media thickness (IMT) was estimated offline, including the right and the left, near and far 
distal common carotid (1 cm), bifurcation, and proximal internal carotid artery, and using an image-
processing dedicated workstation (MediMatic) as previously reported in detail (22). 
Statistical analysis 
Data were analyzed using SPSS20 and expressed as means ± 1 SD. Descriptive statistics were 
performed using ANOVA  and  χ2 distribution. To account for antihypertensive therapy, single 
classes of medications, including anti–renin-angiotensin system (RAS, i.e. ACE inhibitors and/or 
AT1 receptor antagonists), calcium-channel blockers (CCBs), β-blockers, and thiazide diuretics, 
were dichotomized according to their overall use during the individual follow-up, based on the 
frequency of prescription during the control visits. Thus, all medications prescribed for more than 
50% of control visits were considered as covariates in logistic regression analysis. To isolate 
independent predictors of incident ISH we used binary logistic regression, using backward stepwise 
selection of main potential confounders including age, gender, diabetes, obesity, baseline BP, and 
duration of hypertension. In a second step, the markers of preclinical CV disease (LVMi, RWT, 
IMT, PP/SVi)  were added to the first model. Finally, the classes of antihypertensive medications 
were forced into the model as a third step in the hierarchical procedure. A two-tailed p<0.05 was 
considered significant. 
Results 
The median follow-up was 46 months (IQR=24-89 months). At the the time of the last outpatient 
visit, 1339 patients (17%) exibited ISH, 51% of whom were women. Moreover, among our 
hypertensive patients we could identify 483 cases of isolated diastolic hypertension (IDH),  32% of 
whom were women, interestingly none of IDH patients developed ISH. 
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The initial demographic and clinical characteristics of patients with or without follow-up 
progression to ISH are listed in Table 1. As shown in this table, patients developing ISH were 
older, more often   women and  diabetic (all p<0.0001) and had higher initial systolic and lower 
diastolic BP, producing a clear difference in pulse pressure. Duration of hypertension was also 
significantly greater in patients progressing to ISH all p <0.0001). The two groups had not 
significant differences in heart rate, BMI, average number of antihypertensive medications and 
prevalence of smokers. Fasting glucose was higher and GFR lower in patients progressing to ISH 
(both p<0.0001), whereas lipid profile and electrolytes were similar in the two groups.  
Patient developing ISH exhibited higher baseline LV internal dimension, LVMi, RWT, arterial 
stiffness, and IMT than those without incident ISH (Table 2, all p<0.001). Accordingly, the 
prevalence of baseline carotid plaque was also significantly greater in patients with (55%) than in 
those without (41%)  incident ISH (OR=1.80 [1.57-2.05], p<0.0001).In multivariable logistic 
regression, probability of progression to ISH was independently predicted by female gender 
(p<0.001), older age, higher baseline SBP, lower DBP, longer duration of hypertension, higher 
values of  baseline LVMi, RWT, PP/SVi, IMT (all p<0.0001) and  the lack of anti-RAS (ACE-
inhibitors and/or angiotensin receptor blockers) prescription (p<0.04), with no significant effect for 
diabetes, BMI and other classes of antihypertensive medications (Table 3). Interestingly the 
association of incident ISH with diabetes was significant (OR=1.26, 1.03-1.53, p<0.02) until 
markers of CV damage were added to the model. Forcing classes of anti-hypertensive medications 
did not change the phenotypic profile at risk of evolution toward ISH. Classes of anti-hypertensive 
therapy were not independently related to development of ISH. 
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Discussion 
This analysis demonstrate that in the context of arterial hypertension, the evolution toward ISH is 
actually a progression and can be predicted by a number of characteristics that define a specific 
phenotype at risk. Hypertensive patients evolving more often to ISH are older women with higher 
pulse pressure, signs of target organ damage, specifically increased LVMi, concentric LV geometry, 
and increased arterial stiffness. Our findings also suggest that transformation of a combined 
systolic-diastolic hypertension into ISH is related to the progression of arteriosclerotic disease, 
further reducing distensibility and elastic recoil of conduit arteries. ISH is the most common 
hypertension subtype for patients aged between 50 and 59 years, and it is the overwhelmingly 
dominant hypertensive subtype in the sixth decade of life. (23) ISH is characterized by elevated 
systolic BP in the presence of normal or decreased diastolic BP and it is associated with 
substantially increased pulse pressure and with an increased risk for adverse CV outcomes. In the 
Framingham Heart Study, systolic BP was a better independent predictor of CV risk than diastolic 
BP, particularly in patients over 50 years. (24;25) Staessen et al. (6) reported that in elderly patients 
with ISH, risk of death was associated positively with systolic BP and negatively with diastolic BP.  
In the Framingham Heart Study population, (8) including subjects free of anti-hypertensive therapy 
and CV disease, according to baseline BP values, the group which had highest probability to 
develop ISH was the one which had normal or high-normal basal BP compared to the group that 
had basal systo-diastolic hypertension. The best independent clinical risk factors for new-onset ISH 
were age, female gender, and increased BMI during follow-up. In contrast with the Framingham 
population, (8) we studied patients with diastolic hypertension with or without high systolic BP, on 
antihypertensive treatment, also considering the impact of treatment and of markers of preclinical 
disease. Similar to the Framingham Heart Study, aging and female sex were two important 
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characteristics for evolution toward ISH. Another important difference from our study is that in the 
Framingham Heart Study the condition of preclinical CV disease (26) was not considered. This 
difference is substantial, and explains why we did not find an independent effect of diabetes and 
obesity, which was reported in the Framingham Heart Study. In our logistic model we considered 
both risk factors, but also the clinically unapparent consequences of exposition to those risk factors. 
Our analysis suggests that concentric LVH, increased carotid IMT and high arterial stiffness, albeit 
in the presence of diastolic hypertension, already express CV conditions that will progress to ISH. 
Our findings indicate that once the organ damage is established, the direct link between exposition 
to risk factors and overt CV disease is interrupted. Accordingly,  ISH might be considered a further 
step in the progression from atherogenic risk factors exposition to CV adverse events, proposed by 
Devereux and Aldermann (26). This progression seems to be the result of the progressive stiffening 
of conduit arterial system, in part related to age, but also to the greater susceptibility to, and/or to 
the greater severity of, atherosclerotic disease, documented by the more severe target organ damage. 
Interestingly, women are more exposed than men to this progression, a finding that needs to be 
examined in depth. This scenario is consistent with the evidence that ISH is the most severe form of 
hypertension (6) and also more difficult to control than diastolic BP. Normalization of systolic BP 
in the context of ISH is a difficult challenge (27). It is possible that a greater effort should be paid to 
prevent progression to ISH.  Our findings support current recommendations by guidelines, 
(14;28;29) to prompt aggressive therapy for arterial hypertension before the onset of target organ 
damage, to reduce global CV risk. This strategy might be very important to control incidence of 
ISH especially in elderly female patients.  
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Tables 
Table 1. Baseline demographic and clinical characteristics dichotomized by evidence of 
follow-up ISH 
 
 No follow-
up ISH 
(n = 6462) 
Follow-up 
ISH 
(n = 1339) 
p 
Age, years 51.2±10.7 56.8±11.0 <0.0001 
Women, % 41.8 50.9 <0.0001 
Body Mass Index, kg/m
2
 27.8±4.1 27.8±4.2 ns 
systolic BP, mmHg 157.4±19.4 162.1±19.5 <0.0001 
diastolic BP, mmHg 100.5±9.3 99.4±8.1 <0.0001 
Heart rate, bpm 71.8±11.8 71.9±11.9 ns 
Duration of hypertension, years 10.7±7.5 13.4±8.9 <0.0001 
Average number of 
antihypertensive medications 
1.7±1.1 1.8±1.1 ns 
Diabetes, % 11.3 18.9 <0.0001 
Smoking habits, % 48.6 45.9 ns 
Fasting glucose, mmol/L 5.44±1.17 5.61±1.44 <0.0001 
Total cholesterol, mmol/L 5.3±1.0 5.4±1.0 ns 
HDL-cholesterol, mmol/L 1.3±0.3 1.3±0.3 ns 
Triglycerides, mmol/L 1.5±0.9 1.5±0.8 ns 
GFR, mL/min/1.73 m
2
 79.5±18.0 77.1±18.3 <0.0001 
Sodium, mmol/L 141.0±3.2 141.2±3.3 ns 
Potassium, mmol/L 4.4±0.4 4.4±0.4 ns 
Values are means ± SD.  BP = blood pressure; HDL = High-density lipoprotein;  
GFR = Glomerular Filtration Rate. 
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Table 2. Baseline target organ damage by evidence of follow-up of ISH 
 No 
follow-up 
ISH 
(n = 6462) 
Follow-up 
ISH 
(n = 1339) 
P 
LVMi, g/m
2.7
 47.4±9.1 49.6±9.8 <0.0001 
LVIDD/ht, cm/m 2.96±0.19 3.00±0.20 <0.0001 
Relative Wall Thickness 0.38±0.03 0.39±0.04 <0.001 
PP/SVi, mmHg/ml/beat*m
2.04
 2.3±0.6 2.6±0.7 <0.0001 
Max IMT, mm 1.5±0.7 1.8±0.8 <0.0001 
Values are means ± SD.  LVMi = Left Ventricular Mass index; PP/SVi = Pulse Pressure/Stroke 
Volume index; IMT = Intima-Media Thickness, LVIDD/ht = Left Ventricular Internal Diastolic 
Diameter/height. 
 
 
Table 3 Independent predictors of follow-up ISH at logistic regression  
Predictors OR 95% C.I.for OR p 
Lower- Upper 
Female sex 1.29 1.12- 1.50 <0.001 
Age (× 5 yrs) 1.14 1.10- 1.18 <0.0001 
Systolic BP (× 5 mmHg) 1.03 1.01- 1.06 <0.0001 
Diastolic BP (× 5 mmHg) 0.89 0.83- 0.95 <0.0001 
Duration of hypertension (×5 months) 1.11 1.06- 1.16 <0.0001 
LV mass index (× 5 g/m
2.7
) 1.08 1.04- 1.12 <0.0001 
Relative wall thickness 0.02 0.01- 0.15 <0.0001 
PP/SVi 1.99 1.77- 2.23 <0.0001 
Carotid Intima media thickness (mm) 1.19 1.07- 1.33 <0.0001 
Anti-RAS prescription 0.85 0.73- 0.99 <0.04 
Values are means ± SD.  BP = Blood Pressure; LV = Left Ventricular; PP/SVi = Pulse 
Pressure/Stroke Volume index; Anti-RAS = ACE-inhibitors and/or angiotensin receptor blockers. 
 
Diabetes, BMI and other classes of antihypertensive medications did not enter into the final model 
(p>0.05). 
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Figures 
Figure 1 displays the relative contribution of all covariates used in the complete logistic model: the 
initial PP/SVi was by far the most important predictor of ISH followed by age, with the other 
significant components impacting similarly.  
 
 
